Reduction of PTP1B induces differential expression of PI3-kinase (p85alpha) isoforms

Biochemical and Biophysical Research Communications
Cristina M RondinoneJames M Trevillyan

Abstract

Protein tyrosine phosphatase 1B (PTP1B) inhibition increases insulin sensitivity and normalizes blood glucose levels in animals. The molecular events associated with PTP1B inhibition that increase insulin sensitivity remain controversial. Insulin resistant, diabetic ob/ob mice, dosed with PTP1B antisense for 3 weeks exhibited a decrease in PTP1B protein levels and a change in the expression level of p85alpha isoforms in liver, characterized by a reduction in p85alpha and an upregulation of the p50alpha and p55alpha isoforms. Transfection of mouse hepatocytes with PTP1B antisense caused a downregulation PTP1B and p85alpha protein levels. Furthermore, transfection of mouse hepatocytes with PTP1B siRNA downregulated p85alpha protein expression and enhanced insulin-induced PKB phosphorylation. Treatment of mouse hepatocytes with p85alpha antisense oligonucleotide caused a reduction of p85alpha and an increase in p50alpha and p55alpha isoforms and enhanced insulin-stimulated PKB activation. These results demonstrate that PTP1B inhibition causes a direct differential regulation of p85alpha isoforms of PI3-kinase in liver and that reduction of p85alpha may be one mechanism by which PTP1B inhibition improves insulin sensitivity and glu...Continue Reading

References

Aug 2, 1994·Proceedings of the National Academy of Sciences of the United States of America·K HaraT R Jackson
Jul 25, 1997·The Journal of Biological Chemistry·P R ShepherdH Wallberg-Henriksson
Jul 25, 1998·The Biochemical Journal·P R ShepherdK Siddle
Oct 6, 1998·Annual Review of Biochemistry·D A FrumanL C Cantley
Jun 1, 2002·Science·Lewis C Cantley
Aug 10, 2002·Proceedings of the National Academy of Sciences of the United States of America·Bradley A ZinkerMichael R Jirousek
Dec 31, 2002·Biochemical and Biophysical Research Communications·Jill E ClampitCristina M Rondinone
Jun 5, 2003·Molecular and Cellular Endocrinology·Jeffrey F WaringCristina M Rondinone

❮ Previous
Next ❯

Citations

Dec 23, 2004·American Journal of Physiology. Endocrinology and Metabolism·Carrie E McCurdyGregory D Cartee
Oct 8, 2020·Nucleic Acid Therapeutics·Suxiang ChenRakesh N Veedu
Mar 2, 2005·Biochemical and Biophysical Research Communications·Jianfeng XuWeida Huang

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.